Guorui Properties Ltd (HK:2329)
:2329
Want to see HK:2329 full AI Analyst Report?
Top Page
Guorui Properties Ltd
(2329)
Select Model
Select Model
Rating:42Neutral
Price Target:
HK$0.11
▼(-22.14% Downside)
Action:Reiterated
Date:05/07/26
The score is held down primarily by weak financial performance (sharp profitability deterioration, high and rising leverage, and a major 2025 cash flow contraction). Technicals add further pressure with price below major moving averages and a negative MACD, while valuation provides limited support due to a negative P/E and no dividend yield data.
Positive Factors
Positive equity buffer
Balance-sheet equity remains positive rather than a negative-equity (insolvency) profile. That buffer reduces immediate solvency risk, preserves legal capital and supports continued access to lenders or buyers, helping the firm manage project completion and refinancing over months.
Negative Factors
Sharp profitability deterioration
A ~50% revenue collapse and deeply negative gross and net margins in 2025 signal material issues with pricing, cost control or write-downs. Sustained losses impair the firm's ability to reinvest, complete projects and generate returns, weakening earnings stability over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Positive equity buffer
Balance-sheet equity remains positive rather than a negative-equity (insolvency) profile. That buffer reduces immediate solvency risk, preserves legal capital and supports continued access to lenders or buyers, helping the firm manage project completion and refinancing over months.
Read all positive factors
Guorui Properties Ltd (2329) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$457.78M
Dividend YieldN/A
Average Volume (3M)2.01M
Price to Earnings (P/E)―
Beta (1Y)1.17
Revenue Growth-62.05%
EPS Growth-47.92%
CountryHK
Employees448
SectorReal Estate
Sector Strength53
IndustryReal Estate - Development
Share Statistics
EPS (TTM)-0.41
Shares Outstanding4,444,418,000
10 Day Avg. Volume691,400
30 Day Avg. Volume2,011,266
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.06
Price to Sales (P/S)0.49
P/FCF Ratio33.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Guorui Properties Ltd Business Overview & Revenue Model
Company Description
Glory Health Industry Limited, an investment holding company, engages in the development of real estate properties in the People's Republic of China. The company operates through four segments: Property Development, Primary Land Construction and D...
How the Company Makes Money
Guorui Properties Ltd primarily makes money by developing real estate projects and selling completed properties to end buyers, recognizing revenue from contracted sales/handovers in accordance with applicable accounting standards. Additional reven...
Guorui Properties Ltd Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
28
Negative
Cash Flow
22
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.04B | 2.71B | 2.51B | 3.90B | 9.90B |
| Gross Profit | -308.09M | 555.56M | -50.28M | 113.52M | 1.25B |
| EBITDA | -696.90M | 295.14M | -145.86M | -325.93M | 581.55M |
| Net Income | -1.82B | -1.24B | -563.97M | -912.78M | 228.33M |
Balance Sheet | |||||
| Total Assets | 56.70B | 57.20B | 56.35B | 57.39B | 61.07B |
| Cash, Cash Equivalents and Short-Term Investments | 138.18M | 158.10M | 152.22M | 189.51M | 556.87M |
| Total Debt | 23.83B | 22.79B | 22.18B | 21.25B | 20.95B |
| Total Liabilities | 46.10B | 44.83B | 42.57B | 43.01B | 45.64B |
| Stockholders Equity | 8.11B | 9.93B | 11.17B | 11.73B | 12.71B |
Cash Flow | |||||
| Free Cash Flow | 15.19M | 678.26M | 452.11M | 413.47M | 4.07B |
| Operating Cash Flow | 36.24M | 679.53M | 512.92M | 606.31M | 4.35B |
| Investing Cash Flow | -861.82M | 146.72M | 58.95M | -305.41M | 184.15M |
| Financing Cash Flow | 777.99M | -830.50M | -627.40M | -630.90M | -5.65B |
Guorui Properties Ltd Technical Analysis
Negative
0.14
Price Trends
0.11
Negative
0.12
Negative
0.14
Negative
Market Momentum
<0.01
Negative
47.86
Neutral
31.14
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2329, the sentiment is Negative. The current price of 0.14 is above the 20-day moving average (MA) of 0.11, above the 50-day MA of 0.11, and above the 200-day MA of 0.14, indicating a bearish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 47.86 is Neutral, neither overbought nor oversold. The STOCH value of 31.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2329.
Guorui Properties Ltd Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
53 Neutral | HK$221.84M | -27.53 | -0.95% | ― | 18.57% | 82.67% | |
42 Neutral | HK$457.78M | -0.28 | -13.99% | ― | -62.05% | -47.92% | |
42 Neutral | HK$108.53M | -0.03 | -35.96% | ― | -25.77% | -32.32% | |
41 Neutral | HK$195.84M | -0.06 | -34.31% | ― | -69.02% | -41.71% | |
40 Underperform | HK$74.25M | >-0.01 | 77.11% | ― | -70.62% | -155.99% |
* Real Estate Sector Average
HK:2329
Guorui Properties Ltd
0.10
0.06
164.10%
HK:6158
Zhenro Properties Group Limited
0.02
-0.02
-57.50%
HK:0865
Jiande International Holdings Ltd.
0.04
>-0.01
-15.56%
HK:2772
Zhongliang Holdings Group Company Limited
0.04
-0.04
-46.34%
HK:3639
Yida China Holdings Ltd.
0.04
-0.03
-40.00%
Guorui Properties Ltd Corporate Events
Glory Health Industry Posts Deeper 2025 Loss Despite RMB2.1 Billion in Contracted Sales
Mar 31, 2026
Glory Health Industry Limited reported that contracted sales for 2025 reached RMB2,122.7 million, while revenue from property development was RMB606.6 million amid pressure in the rental market. The company’s total revenue fell to RMB1,035.6...
Glory Health Industry Sets March 31 Board Meeting to Approve 2025 Results
Mar 18, 2026
Glory Health Industry Limited has scheduled a board meeting for March 31, 2026 to review and approve the consolidated annual results for the year ended December 31, 2025 and to authorize their publication. The board will also consider whether to r...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.